# Rectal Preserving Treatment for Early Rectal Cancer. A Multi-centred Randomised Trial of Radical Surgery Versus Adjuvant Chemoradiotherapy After Local Excision for Early Rectal Cancers

> **NCT02371304** · PHASE3 · UNKNOWN · sponsor: **Amsterdam UMC, location VUmc** · enrollment: 302 (estimated)

## Conditions studied

- Rectal Cancer

## Interventions

- **RADIATION:** Adjuvant chemoradiotherapy
- **PROCEDURE:** Additional TME surgery
- **DRUG:** capecitabine

## Key facts

- **NCT ID:** NCT02371304
- **Lead sponsor:** Amsterdam UMC, location VUmc
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-10
- **Primary completion:** 2022-06
- **Final completion:** 2023-01
- **Target enrollment:** 302 (ESTIMATED)
- **Last updated:** 2020-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02371304

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02371304, "Rectal Preserving Treatment for Early Rectal Cancer. A Multi-centred Randomised Trial of Radical Surgery Versus Adjuvant Chemoradiotherapy After Local Excision for Early Rectal Cancers". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02371304. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*